Cumberland Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Cumberland Pharmaceuticals
CPIX Stock  USD 5.14  0.03  0.58%   
Cumberland Pharmaceuticals financial statements provide useful quarterly and yearly information to potential Cumberland Pharmaceuticals investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Cumberland Pharmaceuticals financial statements helps investors assess Cumberland Pharmaceuticals' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Cumberland Pharmaceuticals' valuation are summarized below:
Gross Profit
31.3 M
Profit Margin
(0.17)
Market Capitalization
72.2 M
Enterprise Value Revenue
2.1235
Revenue
37.9 M
We have found one hundred twenty available fundamental signals for Cumberland Pharmaceuticals, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Cumberland Pharmaceuticals prevailing market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Enterprise Value is likely to rise to about 2.7 T in 2025, whereas Market Cap is likely to drop slightly above 31.7 M in 2025.

Cumberland Pharmaceuticals Total Revenue

39.91 Million

Check Cumberland Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cumberland Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.3 M, Interest Expense of 635.8 K or Selling General Administrative of 9.1 M, as well as many indicators such as Price To Sales Ratio of 0.84, Dividend Yield of 0.0 or PTB Ratio of 0.0. Cumberland financial statements analysis is a perfect complement when working with Cumberland Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Cumberland Pharmaceuticals Correlation against competitors.
For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.

Cumberland Pharmaceuticals Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets79.4 T75.6 T9.7 T
Slightly volatile
Short and Long Term Debt Total21.6 T20.6 T2.6 T
Slightly volatile
Other Current Liabilities27.5 T26.2 T3.4 T
Slightly volatile
Total Current Liabilities33.2 T31.6 T4.1 T
Slightly volatile
Total Stockholder Equity24 T22.9 T2.9 T
Slightly volatile
Property Plant And Equipment Net6.8 T6.5 T827 B
Slightly volatile
Current Deferred Revenue6.6 M6.3 M5.3 M
Slightly volatile
Accounts Payable7.1 M13.9 M7.5 M
Slightly volatile
Cash18.9 T18 T2.3 T
Slightly volatile
Non Current Assets Total41.1 T39.1 T5 T
Slightly volatile
Cash And Short Term Investments18.9 T18 T2.3 T
Slightly volatile
Net Receivables12.3 T11.7 T1.5 T
Slightly volatile
Common Stock Shares Outstanding13.4 M14.1 M16.2 M
Slightly volatile
Liabilities And Stockholders Equity79.4 T75.6 T9.7 T
Slightly volatile
Non Current Liabilities Total22.5 T21.4 T2.7 T
Slightly volatile
Inventory4.2 T4 T512.5 B
Slightly volatile
Other Current Assets2.9 T2.8 T357 B
Slightly volatile
Total Liabilities55.7 T53 T6.8 T
Slightly volatile
Property Plant And Equipment Gross9.3 M8.8 M3 M
Slightly volatile
Total Current Assets38.3 T36.5 T4.7 T
Slightly volatile
Short Term Debt5.7 T5.5 T699.1 B
Slightly volatile
Intangible Assets19.2 M18 M20.3 M
Slightly volatile
Non Currrent Assets Other14.5 T13.8 T1.8 T
Slightly volatile
Other Liabilities9.2 M8.7 M4.8 M
Slightly volatile
Other Assets7.4 M11.6 M8 M
Slightly volatile
Common Stock49.2 T46.8 T6 T
Slightly volatile
Property Plant Equipment6.6 M6.3 M3.8 M
Slightly volatile
Net Tangible Assets4.1 M4.3 M37.2 M
Slightly volatile
Common Stock Total Equity46.2 M44.2 M55.3 M
Slightly volatile
Long Term Debt Total10.8 M17.2 M10 M
Slightly volatile
Non Current Liabilities Other237.5 K250 K2.8 M
Pretty Stable
Deferred Long Term Asset Charges18.6 K19.6 K451.5 K
Slightly volatile
Short and Long Term Debt5 M5.9 M3.6 M
Slightly volatile
Net Invested Capital47.4 M38.1 M65 M
Slightly volatile
Net Working Capital4.6 M4.8 M34.4 M
Slightly volatile
Capital Stock38.9 M46.8 M49.2 M
Slightly volatile
Capital Lease Obligations4 M5.3 M3.3 M
Slightly volatile

Cumberland Pharmaceuticals Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization6.3 M6 M3.3 M
Slightly volatile
Interest Expense635.8 K605.5 K264.4 K
Slightly volatile
Selling General Administrative9.1 M11.1 M9.1 M
Slightly volatile
Selling And Marketing Expenses17.5 M17 M16.3 M
Pretty Stable
Total Revenue39.9 M37.9 M37.2 M
Pretty Stable
Gross Profit33.9 M31.3 M31 M
Very volatile
Other Operating Expenses40.4 M44.3 M39.6 M
Slightly volatile
Research Development5.2 M4.8 M5 M
Slightly volatile
Cost Of Revenue6 M6.6 M6.2 M
Slightly volatile
Total Operating Expenses34.4 M37.7 M33.3 M
Slightly volatile
Non Operating Income Net Other82.3 K86.6 K200 K
Slightly volatile
Interest Income178.6 K334.4 K193 K
Pretty Stable
Discontinued Operations2.4 M1.8 M2.8 M
Slightly volatile
Reconciled Depreciation4.8 M6 M3.6 M
Slightly volatile
Extraordinary Items80 K90 K98.1 K
Slightly volatile

Cumberland Pharmaceuticals Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow35.7 M18.3 M35.7 M
Slightly volatile
Depreciation6.3 T6 T774.3 B
Slightly volatile
Capital Expenditures69.8 B66.5 B8.5 B
Slightly volatile
End Period Cash Flow26.7 M18 M32.5 M
Slightly volatile
Stock Based Compensation286.8 K301.9 K747.4 K
Very volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.840.882.7206
Slightly volatile
PTB Ratio0.00.02.6331
Slightly volatile
Days Sales Outstanding118.4 M112.8 M14.5 M
Slightly volatile
Book Value Per Share1.7 M1.6 M205.5 K
Slightly volatile
Average Payables13.2 M12.6 M8.9 M
Slightly volatile
Stock Based Compensation To Revenue0.01520.0080.0203
Very volatile
Capex To Depreciation0.01040.0111.3725
Slightly volatile
PB Ratio0.00.02.6331
Slightly volatile
EV To Sales72.3 K68.9 K8.8 K
Slightly volatile
Inventory Turnover0.00.00.8239
Slightly volatile
Days Of Inventory On Hand232.8 M221.7 M28.4 M
Slightly volatile
Payables Turnover0.450.47331.1609
Slightly volatile
Sales General And Administrative To Revenue0.180.29380.2461
Slightly volatile
Average Inventory6.1 M6.3 M7.9 M
Slightly volatile
Research And Ddevelopement To Revenue0.10.12720.1319
Slightly volatile
Capex To Revenue1.8 K1.8 K225
Slightly volatile
Cash Per Share1.3 M1.3 M163.7 K
Slightly volatile
Days Payables Outstanding810771460
Slightly volatile
Intangibles To Total Assets0.180.24990.2209
Slightly volatile
Current Ratio1.11.15284.3226
Slightly volatile
Tangible Book Value Per Share273.2 K260.2 K33.3 K
Slightly volatile
Receivables Turnover0.00.04.5958
Slightly volatile
Shareholders Equity Per Share1.7 M1.6 M208.3 K
Slightly volatile
Debt To Equity0.950.90020.3128
Slightly volatile
Capex Per Share5 K4.7 K606
Slightly volatile
Average Receivables6 M10.3 M7.7 M
Slightly volatile
Revenue Per Share1.932.69332.2922
Slightly volatile
Interest Debt Per Share1.5 M1.5 M187.5 K
Slightly volatile
Debt To Assets0.290.27220.131
Slightly volatile
Graham Number3.031.922.7409
Slightly volatile
Operating Cycle351.2 M334.5 M42.9 M
Slightly volatile
Price Book Value Ratio0.00.02.6331
Slightly volatile
Days Of Payables Outstanding810771460
Slightly volatile
Company Equity Multiplier3.473.30731.8958
Slightly volatile
Long Term Debt To Capitalization0.420.39810.1911
Slightly volatile
Total Debt To Capitalization0.50.47370.2016
Slightly volatile
Debt Equity Ratio0.950.90020.3128
Slightly volatile
Quick Ratio0.971.02633.8816
Slightly volatile
Net Income Per E B T1.111.00211.0288
Very volatile
Cash Ratio0.540.56812.663
Slightly volatile
Days Of Inventory Outstanding232.8 M221.7 M28.4 M
Slightly volatile
Days Of Sales Outstanding118.4 M112.8 M14.5 M
Slightly volatile
Price To Book Ratio0.00.02.6331
Slightly volatile
Fixed Asset Turnover0.00.033.3802
Slightly volatile
Debt Ratio0.290.27220.131
Slightly volatile
Price Sales Ratio0.840.882.7206
Slightly volatile
Gross Profit Margin0.940.82610.8406
Slightly volatile
Price Fair Value0.00.02.6331
Slightly volatile

Cumberland Pharmaceuticals Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap31.7 M33.3 M80.5 M
Slightly volatile
Enterprise Value2.7 T2.6 T334.2 B
Slightly volatile

Cumberland Fundamental Market Drivers

Cash And Short Term Investments18 T

Cumberland Upcoming Events

5th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Cumberland Pharmaceuticals Financial Statements

Cumberland Pharmaceuticals investors use historical fundamental indicators, such as Cumberland Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cumberland Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue6.3 M6.6 M
Total Revenue37.9 M39.9 M
Cost Of Revenue6.6 M6 M
Stock Based Compensation To Revenue 0.01  0.02 
Sales General And Administrative To Revenue 0.29  0.18 
Research And Ddevelopement To Revenue 0.13  0.10 
Capex To Revenue1.8 K1.8 K
Revenue Per Share 2.69  1.93 
Ebit Per Revenue(0.17)(0.16)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce

Additional Tools for Cumberland Stock Analysis

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY